Adipocyte-specific inactivation of NAMPT, a key NAD+ biosynthetic enzyme, causes a metabolically unhealthy lean phenotype in female mice during aging

Authors:

Abstract
Defective NAD+ metabolism is associated with aging and age-associated metabolic diseases. In the present study, we provided in-depth metabolic assessments in female mice with adipocyte-specific inactivation of a key NAD+ biosynthetic enzyme NAMPT and revealed an unexpected role of adipose tissue NAMPT-NAD+-PPAR-γ axis in maintaining functional integrity and quantity of adipose tissue and whole body metabolic health during the aging process.
Funding Information
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R0DK104995)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R0DK126622)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R0DK131009)
  • HHS | NIH | National Heart, Lung, and Blood Institute (R01HL147968)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R56DK115764)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK117657)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020579)
  • HHS | NIH | National Cancer Institute (P30CA091842)
  • HHS | NIH | National Center for Advancing Translational Sciences (UL1TR002345)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020572)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (U2CDK110678)
  • MEXT | Japan Society for the Promotion of Science (20K23382)
  • MEXT | Japan Society for the Promotion of Science (24K02506)
  • Astellas Pharma